The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease

Detalles Bibliográficos
Autores principales: Cronin, Robert M., Lin, Chyongchiou J., Chiang, ChienWei, MacEwan, Sarah R., DeBaun, Michael R., Hyer, J. Madison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362533/
https://www.ncbi.nlm.nih.gov/pubmed/36883847
http://dx.doi.org/10.1182/bloodadvances.2022008965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362533/
https://www.ncbi.nlm.nih.gov/pubmed/36883847
http://dx.doi.org/10.1182/bloodadvances.2022008965

Ejemplares similares